Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Julien Dreyfus Added: 1 year ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more
Author(s): Sean Lyden Added: 1 year ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more
Added: 11 months ago Source:  Radcliffe Cardiology
23 Jun 2025 – Buckinghamshire, UKRadcliffe Group is delighted to report strong Impact Factor growth across its journals in the latest Journal Citation Reports™ (2024) from Clarivate™. This progress highlights the strength and influence of Radcliffe’s cardiovascular portfolio, made possible by the dedicated efforts of its editorial teams, authors, and reviewers.Cardiac Failure Review (CFR), under… View more
Research Area(s) / Expertise:

Expertise

Job title: Medical Affairs Director for Asia-Pacific (Structural Heart)
Prof Rafał Dworakowski, MD (Hons), PhD, FRCP, FESC is an interventional cardiologist and academic with over two decades of experience in structural and coronary interventions. He has performed a high volume of TAVI procedures using various platforms via transfemoral and alternative access routes. He is also experienced in echocardiography and cardiac CT imaging.Prof Dworakowski has extensive… View more
Author(s): Brad Wilson , Kendra J Grubb Added: 2 weeks ago
In this Market Watch interview recorded at EuroPCR 2026 in Paris, Brad Wilson speaks with Dr Kendra Grubb, Chief Medical Officer for the structural heart team at Medtronic, about how transcatheter therapy is evolving across the aortic, mitral and tricuspid space.The discussion traces the maturation of TAVR from its early use in high-risk patients to today's wider device range and stronger… View more